11 results
8-K
EX-99.2
HZNP
Horizon Therapeutics Public Ltd Co
8 Aug 23
Horizon Therapeutics plc Reports Second-Quarter 2023 Financial Results
7:11am
Property and ESG NMOSD: Neuromyelitis optica spectrum disorder. | ESG: Environmental, social and governance.
Horizon is a Leading High-Growth … KRYSTEXXA UPLIZNA Our Pipeline Rare Disease Medicines, Intellectual Property and ESG ESG: Environmental, social and governance.
TED and How TEPEZZA
8-K
EX-99.1
HZNP
Horizon Therapeutics Public Ltd Co
2 Nov 22
Results of Operations and Financial Condition
7:06am
shares while preserving capital to continue prioritizing business development.
Environmental, Social and Governance (ESG) Highlights: In August … , the Company published its inaugural Sustainability Accounting Standards Board (SASB) Index as part of its updated 2021 ESG Overview. In addition, the Company
8-K
EX-99.1
HZNP
Horizon Therapeutics Public Ltd Co
3 Aug 22
Horizon Therapeutics plc Reports Second-Quarter 2022 Financial Results and Revises Full-Year 2022 Net Sales and Adjusted EBITDA Guidance
7:06am
and Other ESG Recognitions: The Company has recently been recognized by Fortune in several best workplace awards – in April, the Company was named … and governance (ESG) achievements, in May, the Company was recognized in the U.S. PatientView survey of patient groups, ranking second in overall
8-K
EX-99.1
HZNP
Horizon Therapeutics Public Ltd Co
4 May 22
Horizon Therapeutics plc Reports First-Quarter 2022 Financial Results
7:12am
Director,
Investor Relations and ESG
investor-relations@horizontherapeutics.com
Horizon Therapeutics plc
Condensed Consolidated Statements
- Prev
- 1
- Next